Abivax Sa American Stock Market Value

ABVX Stock   138.35  0.37  0.27%   
Abivax SA's market value is the price at which a share of Abivax SA trades on a public exchange. It measures the collective expectations of Abivax SA American investors about its performance. Abivax SA is trading at 138.35 as of the 24th of December 2025; that is 0.27 percent down since the beginning of the trading day. The stock's open price was 138.72.
With this module, you can estimate the performance of a buy and hold strategy of Abivax SA American and determine expected loss or profit from investing in Abivax SA over a given investment horizon. Check out Abivax SA Correlation, Abivax SA Volatility and Abivax SA Alpha and Beta module to complement your research on Abivax SA.
Symbol

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abivax SA. If investors know Abivax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abivax SA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abivax SA American is measured differently than its book value, which is the value of Abivax that is recorded on the company's balance sheet. Investors also form their own opinion of Abivax SA's value that differs from its market value or its book value, called intrinsic value, which is Abivax SA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abivax SA's market value can be influenced by many factors that don't directly affect Abivax SA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abivax SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abivax SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abivax SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Abivax SA 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Abivax SA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Abivax SA.
0.00
01/04/2024
No Change 0.00  0.0 
In 1 year 11 months and 22 days
12/24/2025
0.00
If you would invest  0.00  in Abivax SA on January 4, 2024 and sell it all today you would earn a total of 0.00 from holding Abivax SA American or generate 0.0% return on investment in Abivax SA over 720 days. Abivax SA is related to or competes with Rhythm Pharmaceuticals, Merus BV, Cytokinetics, Axsome Therapeutics, Halozyme Therapeutics, Nuvalent, and Jazz Pharmaceuticals. More

Abivax SA Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Abivax SA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Abivax SA American upside and downside potential and time the market with a certain degree of confidence.

Abivax SA Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Abivax SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Abivax SA's standard deviation. In reality, there are many statistical measures that can use Abivax SA historical prices to predict the future Abivax SA's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abivax SA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
141.02145.21149.40
Details
Intrinsic
Valuation
LowRealHigh
122.88127.07161.61
Details
Naive
Forecast
LowNextHigh
145.52149.71153.90
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
76.59107.14137.70
Details

Abivax SA American Backtested Returns

Abivax SA appears to be very steady, given 3 months investment horizon. Abivax SA American secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22 % return per unit of risk over the last 3 months. By analyzing Abivax SA's technical indicators, you can evaluate if the expected return of 0.92% is justified by implied risk. Please makes use of Abivax SA's Risk Adjusted Performance of 0.1617, mean deviation of 2.89, and Downside Deviation of 3.02 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Abivax SA holds a performance score of 17. The firm shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Abivax SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Abivax SA is expected to be smaller as well. Please check Abivax SA's sortino ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Abivax SA's price patterns will revert.

Auto-correlation

    
  -0.86  

Excellent reverse predictability

Abivax SA American has excellent reverse predictability. Overlapping area represents the amount of predictability between Abivax SA time series from 4th of January 2024 to 29th of December 2024 and 29th of December 2024 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Abivax SA American price movement. The serial correlation of -0.86 indicates that approximately 86.0% of current Abivax SA price fluctuation can be explain by its past prices.
Correlation Coefficient-0.86
Spearman Rank Test-0.55
Residual Average0.0
Price Variance2015.75

Abivax SA American lagged returns against current returns

Autocorrelation, which is Abivax SA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Abivax SA's stock expected returns. We can calculate the autocorrelation of Abivax SA returns to help us make a trade decision. For example, suppose you find that Abivax SA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Abivax SA regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Abivax SA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Abivax SA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Abivax SA stock over time.
   Current vs Lagged Prices   
       Timeline  

Abivax SA Lagged Returns

When evaluating Abivax SA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Abivax SA stock have on its future price. Abivax SA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Abivax SA autocorrelation shows the relationship between Abivax SA stock current value and its past values and can show if there is a momentum factor associated with investing in Abivax SA American.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Abivax Stock Analysis

When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.